Mekonos

United States
Alameda, California, United States, 94501

Company profile

Mekonos company profile

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed technology company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug discovery and development.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-05-01, Month

Headquarters

Postal code
94501
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$31M
Last funding
Series A / $25M / 2021-11-09
Last equity funding
Series A / $25M
Investors
17
Lead investors
5
Founders
3
Articles
31

Founders and investors

Founders

Anil NarasimhaGreg SittersSteven Banerjee

Lead investors

Elementum VenturesFiscus VenturesNovartisPeak 6Reimagined Ventures

Investors

NovartisS32Sands Capital VenturesSkyDeck BerkeleyTDK Ventures